Cargando…

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine

Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. A virus-like particle (VLP) candidate vaccine induces the production of serum histo-blood group antigen (HBGA)-blocking antibodies, the first identified correlate of protection from HuNoV gastroenteritis. Recently, vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramani, Sasirekha, Neill, Frederick H., Ferreira, Jennifer, Treanor, John J., Frey, Sharon E., Topham, David J., Goodwin, Robert R., Borkowski, Astrid, Baehner, Frank, Mendelman, Paul M., Estes, Mary K., Atmar, Robert L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Vaccines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424242/ https://www.ncbi.nlm.nih.gov/pubmed/28249841 http://dx.doi.org/10.1128/CVI.00571-16

Ejemplares similares

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial
por: López, Pio, et al.
Publicado: (2023)

2650. Evaluating Antiviral Agents for Human Noroviruses Using a Human Intestinal Enteroid Model
por: Cortes-Penfield, Nicolas W, et al.
Publicado: (2019)

Bivalent Norovirus VLP Vaccine Candidate in Older Adults: Impact of MPL and a Second Dose in a Randomized, Controlled, Double-Blind Clinical Trial
por: Sherwood, Jim, et al.
Publicado: (2017)

Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
por: Ramani, Sasirekha, et al.
Publicado: (2016)

Norovirus in Cancer Patients: A Review
por: Kondapi, Divya Samantha, et al.
Publicado: (2021)

Glycan Recognition in Human Norovirus Infections
por: Tenge, Victoria R., et al.
Publicado: (2021)

Norovirus Protease Structure and Antivirals Development
por: Zhao, Boyang, et al.
Publicado: (2021)

1098. Norovirus Infection in Cancer Patients Undergoing Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T)
por: Kondapi, Divya S, et al.
Publicado: (2020)

700. Risk Factors and Molecular Epidemiology of Acute and Chronic Norovirus Infection at a Large Tertiary Care Cancer Center
por: Kondapi, Divya S, et al.
Publicado: (2021)

2276. Immunogenicity of Takeda’s Bivalent Virus-Like Particle (VLP) Norovirus Vaccine (NoV) Candidate in Children From 6 Months up to 4 Years of Age
por: Masuda, Taisei, et al.
Publicado: (2018)

A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide
por: Lewis, Miranda A., et al.
Publicado: (2023)

New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal Enteroids
por: Ettayebi, Khalil, et al.
Publicado: (2021)

Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial
por: Leroux-Roels, Geert, et al.
Publicado: (2018)

Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection
por: Haga, Kei, et al.
Publicado: (2020)

Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response
por: Su, Lynn, et al.
Publicado: (2023)

Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally
por: Liao, Yun, et al.
Publicado: (2023)

Norovirus disease: changing epidemiology and host susceptibility factors
por: Hutson, Anne M, et al.
Publicado: (2004)

Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses
por: Ettayebi, Khalil, et al.
Publicado: (2022)

Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses
por: Crawford, Sue E, et al.
Publicado: (2012)

Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges
por: Estes, Mary K., et al.
Publicado: (2019)

Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity
por: Hu, Liya, et al.
Publicado: (2022)

Structural Biology of Noroviruses
por: Venkataram Prasad, B.V., et al.
Publicado: (2016)

Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial
por: Lindesmith, Lisa C., et al.
Publicado: (2015)

A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection
por: Ao, Zhujun, et al.
Publicado: (2022)

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
por: Riddle, Mark S., et al.
Publicado: (2016)

Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products
por: Sears, Khandra T., et al.
Publicado: (2017)

Piliation of Invasive Streptococcus pneumoniae Isolates in the Era before Pneumococcal Conjugate Vaccine Introduction in Malawi
por: Kulohoma, Benard W., et al.
Publicado: (2013)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
por: Karasavvas, Nicos, et al.
Publicado: (2015)

Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
por: Ma, Huan, et al.
Publicado: (2021)

Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses
por: Hurwitz, Amy M., et al.
Publicado: (2017)

Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
por: Sow, Samba O., et al.
Publicado: (2017)

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens
por: Karnasuta, Chitraporn, et al.
Publicado: (2017)

CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection
por: Ayyar, B. Vijayalakshmi, et al.
Publicado: (2023)

Norovirus Gastroenteritis in a Birth Cohort in Southern India
por: Menon, Vipin Kumar, et al.
Publicado: (2016)

606 Noroviruses (NoVs) as a Cause of Diarrhea in Immunocompromised Pediatric Transplant Recipients
por: Koo, Hoonmo L., et al.
Publicado: (2014)

Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?
por: Petersen, Karin Dam, et al.
Publicado: (2011)

Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development
por: Brehony, Carina, et al.
Publicado: (2014)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
por: Harris, Stephanie A., et al.
Publicado: (2014)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Characterization of T-Cell Responses to Conserved Regions of the HIV-1 Proteome in BALB/c Mice
por: Ondondo, Beatrice, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_873u8sqisqluk42p6lkk7seabh